# Weight-Loss Drug by Eli Lilly Shows 94% Reduction in Diabetes Risk in Three-Year Trial – Eli Lilly’s weight-loss drug has shown a significant 94% reduction in diabetes risk during a three-year clinical trial. – Participants who used the drug experienced an average weight loss of over 13 pounds compared to the placebo group. – The drug works by targeting specific brain receptors to regulate appetite, leading to successful weight loss and better health outcomes. – This promising development highlights the potential of pharmaceutical interventions in addressing obesity-related health issues. ### Taking proactive steps towards weight loss can greatly reduce the risk of developing chronic conditions like diabetes. Partnering with healthcare professionals can help individuals achieve their weight loss goals effectively and safely. **Contact Mindful Evolution today to learn more about our telehealth services in Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, New York, South Carolina, Tennessee, Texas, and Virginia. Reach out to us for personalized support on your weight loss journey.** **Weight Loss Disclaimer:** Results may vary. Weight loss is influenced by exercise, food consumed, and diet.